Brought to you by 
Singulex brings in $19mm through Series E venture round
09 Jun 2011
Executive Summary
Singulex (immunoassays) raised $19mm through its Series E venture round. JAFCO led and was joined by returning backers OrbiMed Advisors and Fisk Ventures. An officer from JAFCO Life Science Investment will take a seat on Singulex's board.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com